Subscribe to RSS
DOI: 10.1055/s-2007-982038
© Georg Thieme Verlag KG Stuttgart · New York
Pneumologie 2007
Diseases of the lung and air passages 2007Publication History
eingereicht: 14.5.2007
akzeptiert: 16.5.2007
Publication Date:
15 June 2007 (online)
Was ist neu?
-
Asthma bronchiale: neue Leitlinien, Antibiotika, Deeskalation der Therapie
-
COPD: Prognoseabschätzung, Roflumilast, TORCH-Studie
-
Lungengerüsterkrankungen: Verlaufsabschätzung, positive Effekte von Cyclophosphamid
-
Schlafbezogene Atemstörungen: Zusammenhang mit Schlaganfall?
-
Lungenembolie: Wann lysieren?
-
Pulmonale Hypertonie und Bewegung
-
Bronchialkarzinom: Platin von Vorteil.
-
Pneumonie: Wie einschätzen, wann Therapie beginnen?
-
Intensivmedizin: Probleme beim Weaning
Literatur
- 1 Arzt M, Young T, Finn L. et al . Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005; 11 1447-1451
- 2 Bateman E D, Jacques L, Goldfrad C. et al . Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol. 2006; 3 563-570
- 3 Bauer T T, Ewig S, Marre R. et al . CRB-65 predicts death from community-acquired pneumonia. J Intern Med. 2006; 1 93-101
- 4 Binder L, Pieske B, Olschewski M. et al . N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation. 2005; 11 1573-1579
- 5 Calverley P M, Anderson J A, Celli B. et al . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 8 775-789
- 6 Capelastegui A, Espana P P, Quintana J M. et al . Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006; 1 151-157
- 7 Francois B, Bellissant E. et al . 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet. 2007; 9567 1083-1089
- 8 Hotta K, Matsuo K, Ueoka H. et al . Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2004; 19 3852-3859
- 9 Huang C J, Lin H C. Association between adrenal insufficiency and ventilator weaning. Am J Respir Crit Care Med. 2006; 3 276-280
- 10 Jegal Y, Kim D S, Shim T S. et al . Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005; 6 639-644
- 11 Johnston S L, Blasi F, Black P N, Martin R J, Farrell D J, Nieman R B. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med. 2006; 15 1589-1600
- 12 Kumar A, Roberts D, Wood K E. et al . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 6 1589-1596
- 13 Mereles D, Ehlken N. et al . Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006; 14 1482-1489
- 14 Munoz R, Duran-Cantolla J. et al . Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006; 9 2317-2321
- 15 Rabe K F, Bateman E D, O’Donnell D. et al . Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2005; 9485 563-571
- 16 Takigawa N, Tada A, Soda R. et al . Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med. 2007; 3 561-567
- 17 Tashkin D P, Elashoff R, Clements P J. et al . Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006; 25 2655-2666
Priv.-Doz. Dr. med. Dr. rer. nat. Robert Bals
Klinik für Innere Medizin mit Schwerpunkt Pneumologie
Baldingerstraße 1
35043 Marburg
Phone: 06421/2864994
Fax: 06421/2868987
Email: bals@staff.uni-marburg.de